Patented and clinically verified nutraceutical actives outperform current branded offerings and offer a powerful solution for supplement product potency concerns.
LAS VEGAS, Oct. 28, 2024 -- At the Supplyside West tradeshow this week, representatives from Cocrystal Health Industry announced the introduction of Cocrystal
Lutein and
Curcumin powder actives. Supported by 60 global patents and nearly 100 published papers, the company utilizes its proprietary and clean cocrystallization platform to create actives with significantly enhanced bioabsorption, stability, and functionality compared to existing offerings. These launches expand their current cocrystallized ingredient portfolio, which includes
Ubiquinol CoQ10,
Hydroxytyrosol, and
Alpha Tocopherol Vitamin E.
Lutein has been well-documented in clinical research for supporting eye health, though traditional lutein ingredients suffer from poor bioabsorption, solubility, and stability, as the ingredient is prone to oxidation. Powered by Cocrystal Health Industry's vegan, non-GMO, and clean cocrystallization process, Cocrystal Lutein offers an effective solution to these issues. In third-party testing, Cocrystal Lutein exhibited over six times greater bioabsorption and three times better solubility compared to currently marketed lutein. In a direct capsule stability study, Cocrystal Lutein maintained over 99% of its potency after 30 days, while current marketed lutein retained less than 2% of its original potency. Besides performance benefits, the cocrystal technology provides significant cost savings relative to well-known branded lutein.
Curcumin is widely researched for its benefits, including joint and cognitive health, but marketed curcumin extracts face limitations due to very poor bioavailability. Patented Cocrystal Curcumin, featuring
L-Carnitine as a ligand, has been shown in studies to offer over ten times greater bioabsorption compared to current marketed curcumin. While there are various enhanced bioavailability curcumin materials available, in a comparative study, Cocrystal Curcumin exhibited significantly better bioabsorption even relative to an existing enhanced offer.
Alex Mei, Ph.D., Founder & CEO of Cocrystal Health Industry, commented, "We are excited to broaden our portfolio and introduce new solutions with our Cocrystal Lutein & Curcumin technologies. Our proprietary platform addresses multiple nutrition brand concerns – providing meaningful differentiation and unmatched benefit performance to their consumers, while ensuring sustained potency against label claims. As the global leader in cocrystallized active ingredients, we're proud to offer these transformative solutions."
Cocrystal Health Industry, backed by 60 global patents and nearly 100 published papers, introduces cocrystal powder technologies as unprecedented solutions for ingredients with poor stability and low bioavailability. With proven best-in-class bioavailability and superior in-formula stability, their actives also feature pure nature integrity, improved solubility, dissolution, melting point, and flowability compared to existing offerings. Beyond their superior performance, Cocrystal actives typically provide a cost advantage relative to other branded ingredients. The company's expanding portfolio includes
Cocrystal Ubiquinol, Hydroxytyrosol, Alpha Tocopherol, Rutin, and now Lutein and Curcumin.
How to obtain the latest research advancements in the field of biopharmaceuticals?
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!
